Previous 10 | Next 10 |
2023-07-21 08:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NORTHAMPTON, MA / ACCESSWIRE / July 20, 2023 / Quest Diagnostics, through the Quest for Health Equity (Q4HE) initiative, has teamed up with Western University of Health Sciences (WesternU) to offer no-cost diagnostic testing services to support Biopsies Save Lives . This multidisciplinary p...
2023-07-19 07:30:00 ET Summary At Laughing Water Capital, our interests are fully aligned with our partners as nearly all of our personal wealth is invested in our strategy. In the second quarter of 2023, Laughing Water Capital returned approximately 13.8% after all fees and expen...
SECAUCUS, NJ / ACCESSWIRE / July 17, 2023 / Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2023 Disability Equality Index ® (DEI) Best Places to Work for Disability Inclusion by Disability: IN and the Amer...
NORTHAMPTON, MA / ACCESSWIRE / July 13, 2023 / On May 23, several Quest Diagnostics employees volunteered at the Healthy NewsWorks Spring Celebration, featuring achievements of its student reporters from the greater Philadelphia area. A Quest for Health Equity (Q4HE) grantee, Healthy NewsWorks ...
Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading PR Newswire Lab service utilizes Envision Science's proprietary biomarkers and technology with a goal of improving diagnosis and grading of prostate cancer SECAUCUS, N.J. and...
Quest Diagnostics Named a 'Best Place to Work for Disability Inclusion' for Sixth Consecutive Year PR Newswire SECAUCUS, N.J. , July 13, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced...
Quest Launches Consumer-Initiated Genetic Test on questhealth.com to Deliver Personalized, Actionable Health Risk Insights PR Newswire First consumer genetic health test under the Quest brand provides insights based on DNA, with unique features that include next-generation seq...
Analysis of Half a Billion Lipid Tests from Five Continents Reveals Wide Variation of Lipid-Associated Risk of Heart Disease by Country and Sex PR Newswire Organized by nine laboratories on five continents, the study by some members of the Global Diagnostics Network, a Quest D...
Quest and Proov Collaborate to Bring Novel Home Fertility Test to Women Through questhealth.com PR Newswire First and only FDA-cleared PdG (progesterone metabolite) home test to help confirm successful ovulation SECAUCUS, N.J. , July 6, 2023 /PRNewswire/ ...
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
Quest Diagnostics Incorporated Website:
Haystack Oncology and Université de Montréal's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer PR Newswire BALTIMORE, Md. and MONTREAL , July 29, 2024 /PRN...
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-24 07:00:10 ET Eric Coldwell from Robert W. Baird issued a price target of $154.00 for DGX on 2024-07-24 06:36:00. The adjusted price target was set to $154.00. At the time of the announcement, DGX was trading at $140.96. The overall price target consensus is at ...